Home
>
National Drug Code (NDC)
>
EMEND
EMEND - 0006-3884-32 - (FOSAPREPITANT DIMEGLUMINE)
Drug Information of EMEND
| Product NDC: | 0006-3884 |
| Proprietary Name: | EMEND |
| Non Proprietary Name: | FOSAPREPITANT DIMEGLUMINE |
| Active Ingredient(s): | 115 mg/5mL & nbsp; FOSAPREPITANT DIMEGLUMINE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of EMEND
| Product NDC: | 0006-3884 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022023 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080125 |
Package Information of EMEND
| Package NDC: | 0006-3884-32 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3884-32) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-3884-01) |
NDC Information of EMEND
| NDC Code | 0006-3884-32 |
| Proprietary Name | EMEND |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3884-32) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-3884-01) |
| Product NDC | 0006-3884 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | FOSAPREPITANT DIMEGLUMINE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080125 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | FOSAPREPITANT DIMEGLUMINE |
| Strength Number | 115 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
